Sanofi SA
MIL:1SAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
MIL:1SAN
|
FR |
|
A
|
Aramis Group SAS
PAR:ARAMI
|
FR |
|
Finch Therapeutics Group Inc
OTC:FNCH
|
US |
|
I
|
Ionis Pharmaceuticals Inc
F:ISI
|
US |
|
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
US |
|
Nouveau Monde Graphite Inc
XTSX:NOU
|
CA |
|
M
|
Marex Group PLC
NASDAQ:MRX
|
UK |
|
Orthocell Ltd
ASX:OCC
|
AU |
|
Mercury NZ Ltd
NZX:MCY
|
NZ |
|
PriceSmart Inc
NASDAQ:PSMT
|
US |
|
B
|
Bimobject AB
STO:BIM
|
SE |
|
Vera Bradley Inc
NASDAQ:VRA
|
US |
|
BigBear.ai Holdings Inc
NYSE:BBAI
|
US |
|
Netflix Inc
NASDAQ:NFLX
|
US |
|
OneMain Holdings Inc
NYSE:OMF
|
US |
|
Celltrion Inc
KRX:068270
|
KR |
|
LuxExperience BV
F:0FV
|
DE |
|
Sensient Technologies Corp
NYSE:SXT
|
US |
|
Catalyst Metals Ltd
ASX:CYL
|
AU |
Wall St Price Targets
1SAN Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for 1SAN is 97.57 EUR with a low forecast of 57.78 EUR and a high forecast of 118.02 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1SAN's stock price target?
Price Target
97.57
EUR
According to Wall Street analysts, the average 1-year price target for 1SAN is 97.57 EUR with a low forecast of 57.78 EUR and a high forecast of 118.02 EUR.
What is the Revenue forecast for Sanofi SA?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Sanofi SA?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 7%.
What is the Net Income forecast for Sanofi SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 5%.
